China to vaccinate high-risk groups this winter with three inoculations

About This Source - CGTN

This story is an English language news item from CGTN. CGTN is a Chinese state-funded broadcaster.

Recent from CGTN:

  • The Point: Next phase of the new coronavirus origin studies
  • VOXPOP: How much do people in China know about Tokyo Olympic Games?
  • Live: Discover the city of Changsha through Taiping Old Street
  • CGTN published this video item, entitled “China to vaccinate high-risk groups this winter with three inoculations” – below is their description.

    For more:

    https://www.cgtn.com/video

    China has approved emergency use of three COVID-19 vaccines in June, two from CNBG Sinopharm and one from Sinovac. The State Council task force on COVID-19 says since emergency use started in July, more than one million doses have been administered.

    China has approved the emergency use of three COVID-19 vaccines in June, two from CNBG Sinopharm and one from Sinovac. The State Council task force on COVID-19 says since emergency use started in July, more than one million doses have been administered.

    CGTN YouTube Channel

    Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.

    In This Story: COVID-19

    Covid-19 is the official WHO name given to the novel coronavirus which broke out in late 2019 and began to spread in the early months of 2020.

    Symptoms of coronavirus

    The main symptoms of coronavirus are:

    • a persistent new cough (non productive, dry)
    • a high temperature (e.g. head feels warm to the touch)
    • shortness of breath (if this is abnormal for the individual, or increased)

    Latest News about Covid-19

    Below are stories from around the globe related to the 2020 outbreak of novel Coronavirus – since the WHO gave the Covid-19 naming. Most recent items are posted nearest the top.

    5 Recent Items: COVID-19

  • Scale of Sars-Cov-2 immunity still unclear | COVID-19 Special
  • Tanzania Kicks Off Covid-19 Vaccination Campaign
  • Family of Sean Turnell study new photos of him detained in virus-hit Myanmar | The World
  • COVID -19: Kenya’s COVID vaccine supply is dwindling
  • Former DHS secretary slams Biden admin over migrant COVID-19 outbreak
  • In This Story: Sinopharm

    China National Pharmaceutical Group Corp. known as Sinopharm is a Chinese state-owned enterprise. The corporation was the indirect major shareholder of publicly traded companies Sinopharm Group, China Traditional Chinese Medicine. Shanghai Shyndec Pharmaceutical and Beijing Tiantan Biological Products.

    2 Recent Items: Sinopharm

  • How a Senegal lab may be Africa’s pandemic game changer | COVID-19 Special
  • Live: Headline Buster – Why is the media stirring up controversy over Chinese vaccines?
  • Leave a Comment